3 ms·
Of course, the marginal cost of production is low at scale. Most of the mark-up is for advertising and overhead. Also, once it goes generic that will hurt futur
by paulpauper 3y ago
Of course, the marginal cost of production is low at scale. Most of the mark-up is for advertising and overhead. Also, once it goes generic that will hurt future sales too.
- lxgr 3y agoNo, it’s for the massive upfront cost of research and regulatory approval. The stuff basically sells itself at this point; marketing probably doesn’t even register in their budget for it.
- paulpauper 3y agothat is what overhead is
- lxgr 3y agoIf you can find a way to cut the overhead of researching new (safe) pharmaceuticals, please do immediately start a company! We could have all kinds of interesting discussions around the parallels between research funding and tech VCs, sprawling regulations and delayed approval procedures etc., but even in a libertarian utopia without an FDA I think you'll find that all researches like getting paid at the end of the month consistently, and not just the few that do eventually hit the jackpot.